









市場
/
株式
/
nasdaq-foxo
/

Foxo Technologies Inc

FOXO

0.092USD

0.000

終値 09/19, 16:00（ET）15分遅れの株価

31.56K時価総額

損失額直近12ヶ月PER



Foxo Technologies Inc

0.092

0.000

概要企業名金融分析

FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.

企業情報

企業コードFOXO

会社名Foxo Technologies Inc

上場日Dec 11, 2020

最高経営責任者「CEO」Mr. Seamus Lagan

従業員数- -

証券種類Ordinary Share

決算期末Dec 11

本社所在地477 South Rosemary Avenue

都市WEST PALM BEACH

証券取引所US 'Other OTC' and Grey Market

国United States of America

郵便番号33401

電話番号16128000059

ウェブサイトhttp://delwinds.com/

企業コードFOXO

上場日Dec 11, 2020

最高経営責任者「CEO」Mr. Seamus Lagan

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Bret Barnes

Independent Chairman of the Board

168.00

+0.60%

Mr. Seamus Lagan

Chief Executive Officer, Interim Chief Financial Officer, Director

Mr. Trevor Langley

Director

Mr. Francis Colt Dewolf, III

Independent Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Bret Barnes

Independent Chairman of the Board

168.00

+0.60%

Mr. Seamus Lagan

Chief Executive Officer, Interim Chief Financial Officer, Director

Mr. Trevor Langley

Director

Mr. Francis Colt Dewolf, III

Independent Director

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Sat, Aug 16

株主統計

種類

株主統計

比率

Rennova Health, Inc.

0.11%

UBS Financial Services, Inc.

0.10%

Clearthink Capital Partners LLC

0.07%

Jane Street Capital, L.L.C.

0.04%

Two Sigma Investments, LP

0.04%

他の

99.65%

株主統計

比率

Rennova Health, Inc.

0.11%

UBS Financial Services, Inc.

0.10%

Clearthink Capital Partners LLC

0.07%

Jane Street Capital, L.L.C.

0.04%

Two Sigma Investments, LP

0.04%

他の

99.65%

種類

株主統計

比率

Corporation

0.20%

Investment Advisor

0.13%

Research Firm

0.06%

Hedge Fund

0.04%

Investment Advisor/Hedge Fund

0.02%

他の

99.55%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

122.62K

2.30%

-40.72K

2025Q1

283.42K

16.93%

-74.76K

2024Q4

2.97M

12.59%

-305.11K

2024Q3

2.93M

22.70%

-1.57M

2024Q2

3.17M

26.93%

-1.03M

2024Q1

108

4.13M

45.76%

-1.73M

2023Q4

115

3.33M

41.62%

-1.13M

2023Q3

119

2.33M

33.97%

-1.67M

2023Q2

124

2.96M

79.90%

-804.39K

2023Q1

129

1.99M

69.67%

-1.77M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Rennova Health, Inc.

102.36K

0.96%

-1.00

-0.00%

May 21, 2025

UBS Financial Services, Inc.

15.02K

0.14%

+1.03K

+7.33%

Mar 31, 2025

Clearthink Capital Partners LLC

60.00K

0.56%

+60.00K

Dec 01, 2023

Kr8 ai Inc

23.70K

0.22%

-1.00

-0.00%

May 21, 2025

SBI Securities Co., Ltd.

5.10K

0.05%

+1.17K

+29.67%

Mar 31, 2025

Cantor Fitzgerald, L.P

1.91K

0.02%

Mar 31, 2025

HRT Financial LP

-1.57K

-100.00%

Mar 31, 2025

Geode Capital Management, L.L.C.

14.40K

0.14%

+10.16K

+239.24%

Mar 31, 2025

詳細を見る